atazanavir sulfate has been researched along with oxytetracycline, anhydrous in 2 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (oxytetracycline, anhydrous) | Trials (oxytetracycline, anhydrous) | Recent Studies (post-2010) (oxytetracycline, anhydrous) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 6,721 | 267 | 976 |
| Protein | Taxonomy | atazanavir sulfate (IC50) | oxytetracycline, anhydrous (IC50) |
|---|---|---|---|
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | 1.7087 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, C; Wang, J | 1 |
| Huang, YY; Li, Z; Lin, Y; Liu, R; Luo, HB; Wang, X; Zhan, CG | 1 |
2 other study(ies) available for atazanavir sulfate and oxytetracycline, anhydrous
| Article | Year |
|---|---|
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles | 2021 |
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles | 2021 |